Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
Clinical trial NCT01464762 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT01464762
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.